Sanofi recalls sub-potent H1N1 vaccine batch in US
Sanofi Pasteur has recalled four lots of its pediatric H1N1 vaccine in the US that were found to have fallen below potency limits despite being be in spec at the time of manufacture.
Archives for December 16, 2009
US PTO approves Isis and Alnylam’s new RNAi claims
US drugmakers developers Isis and Alnylam say the US PTO has allowed 75 new claims relating to the development of RNAi drugs.
GSK welcomes UK “patent box” 2013 tax plan
GSK says UK plans to apply a reduced tax rate to all drugs patented after 2013 will encourage investment, provided it is applied to products already being developed.
Instem sets up in Shanghai
US software firm Instem will establish an office in Shanghai, China, to provide customer support, client management, development and sales support to its Chinese pharmaceutical and life sciences R&D clients.
Phase Forward appoints chief privacy officer
US eClinical firm Phase Forward has created the new executive role, “chief privacy officer,” to ensure it complies with the latest data protection and privacy regulations governing the trial sector.